["{\n\"step_by_step_thinking\": \"The question is asking about the effects of atorvastatin on various biomarkers. The relevant information from the provided documents is that atorvastatin is a HMG-CoA reductase inhibitor, which works by reducing intracellular synthesis of cholesterol and increasing receptor-mediated capture of cholesterol, thereby lowering plasma levels.\n\nFrom the document 'Successful dissolution of cholesterol gallstone during treatment with pravastatin', we know that pravastatin decreased biliary cholesterol saturation index, which suggests that it lowered cholesterol levels.\n\nThe document 'Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study)' shows that both simvastatin and pravastatin significantly reduced total cholesterol, LDL-cholesterol, and triglycerides, while increasing HDL-cholesterol.\n\nThe document 'Effect of simvastatin in CAPD patients with hypercholesterolemia' shows that simvastatin lowered serum cholesterol, triglyceride, and LDL-cholesterol levels.\n\nGiven these effects, it is likely that HDL-cholesterol will increase after initiating atorvastatin. Therefore, the correct answer is D: High-density lipoprotein.\",\n\"answer_choice\": \"D\""]